1. Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib. Issue 4 (22nd July 2020) Authors: Rumi, Elisa; Sant'Antonio, Emanuela; Cavalloni, Chiara; Comolli, Giuditta; Ferretti, Virginia Valeria; Cassaniti, Irene; Pietra, Daniela; Trotti, Chiara; Ciboddo, Michele; Furione, Milena; Vanni, Daniele; Casetti, Ilaria Carola; Favaron, Cristina; Baldanti, Fausto; Arcaini, Luca; Cazzola, Mario Journal: Hematological oncology Issue: Volume 38:Issue 4(2020) Page Start: 554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis. Issue 2 (February 2015) Authors: Augello, Claudia; Gianelli, Umberto; Falcone, Rossella; Tabano, Silvia; Savi, Federica; Bonaparte, Eleonora; Ciboddo, Michele; Paganini, Leda; Parafioriti, Antonina; Ricca, Dario; Lonati, Silvia; Cattaneo, Daniele; Fracchiolla, Nicola Stefano; Iurlo, Alessandra; Cortelezzi, Agostino; Bosari, Silv... Journal: Leukemia research Issue: Volume 39:Issue 2(2015:Feb.) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms. Issue 7 (1st May 2019) Authors: Rumi, Elisa; Zibellini, Silvia; Boveri, Emanuela; Cavalloni, Chiara; Riboni, Roberta; Casetti, Ilaria Carola; Ciboddo, Michele; Trotti, Chiara; Favaron, Cristina; Pietra, Daniela; Candido, Chiara; Ferretti, Virginia Valeria; Cazzola, Mario; Arcaini, Luca Journal: American journal of hematology Issue: Volume 94:Issue 7(2019:Jul.) Page Start: E185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗